Latest Stargardt disease Stories
RnRMarketResearch.com adds "Blepharitis - Pipeline Review, H1 2015" to its store. This report provides an overview of the Blepharitis's therapeutic pipeline. DALLAS, Jan.
DOYLESTOWN, Pa., June 10, 2014 /PRNewswire/ -- On June 2, 2014 Makindus, Inc. a specialty pharmaceutical company, received orphan drug designation for their lead product MI-100 from the U.S.
Dr.Burton Feinerman of StemCell RegenMed announces the recruitment of patients diagnosed with Retinitis Pigmentosa, Age related Macular Degeneration and Stargardt Macular Degeneration.
Scientists have improved the eyesight of two people who were nearly blind by injecting their eyes with stem cells from human embryos.
The first ever European trials of human embryonic stem cell therapy will take place before the end of the year.
MARLBOROUGH, Mass., July 14, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc.
MARLBOROUGH, Mass., June 27, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc.
OXFORD, England, June 22, 2011 /PRNewswire/ -- - RetinoStat(R) Progress in Phase I Study in Wet Age-Related Macular Degeneration Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that the first dose level of RetinoStat(R) is safe and well-tolerated at one month following treatment. RetinoStat(R) is a novel gene-based treatment for neovascular "wet" age-related macular degeneration (AMD), designed and...